glucosamine 6-o-sulfate has been researched along with Ovarian Neoplasms in 1 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avizienyte, E; Bugatti, A; Cole, CL; Gardiner, JM; Jayson, GC; Miller, GJ; Presta, M; Rushton, G | 1 |
1 other study(ies) available for glucosamine 6-o-sulfate and Ovarian Neoplasms
| Article | Year |
|---|---|
Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Glucosamine; Heparitin Sulfate; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oligosaccharides; Ovarian Neoplasms; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2016 |